Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Middle | 7 | 2023 | 24 | 2.730 |
Why?
|
| Tympanoplasty | 6 | 2019 | 13 | 2.330 |
Why?
|
| Tympanic Membrane | 9 | 2023 | 13 | 1.950 |
Why?
|
| Tympanic Membrane Perforation | 5 | 2019 | 7 | 1.940 |
Why?
|
| Cholesteatoma | 2 | 2023 | 7 | 1.790 |
Why?
|
| Temporal Bone | 12 | 2019 | 66 | 1.790 |
Why?
|
| Cranial Fossa, Middle | 4 | 2016 | 11 | 1.790 |
Why?
|
| Cochlear Implantation | 4 | 2017 | 31 | 1.770 |
Why?
|
| Otolaryngology | 3 | 2018 | 53 | 1.680 |
Why?
|
| Hearing Loss, Sensorineural | 7 | 2020 | 46 | 1.670 |
Why?
|
| Ear Diseases | 3 | 2020 | 19 | 1.620 |
Why?
|
| Facial Nerve | 5 | 2022 | 33 | 1.550 |
Why?
|
| Otologic Surgical Procedures | 3 | 2018 | 13 | 1.460 |
Why?
|
| Mastoid | 4 | 2018 | 17 | 1.440 |
Why?
|
| Cochlear Implants | 3 | 2019 | 33 | 1.430 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 17 | 1.390 |
Why?
|
| Otitis Externa | 3 | 2019 | 5 | 1.330 |
Why?
|
| Cholesteatoma, Middle Ear | 3 | 2023 | 8 | 1.320 |
Why?
|
| Earache | 2 | 2019 | 4 | 1.240 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 2016 | 3 | 1.110 |
Why?
|
| Ethiopia | 6 | 2020 | 37 | 1.020 |
Why?
|
| Speech Perception | 2 | 2015 | 71 | 0.980 |
Why?
|
| Otitis Media | 1 | 2023 | 18 | 0.920 |
Why?
|
| Hearing Loss, Sudden | 3 | 2014 | 4 | 0.890 |
Why?
|
| Stapes Surgery | 2 | 2019 | 6 | 0.880 |
Why?
|
| Petrous Bone | 1 | 2022 | 11 | 0.870 |
Why?
|
| Cochlea | 2 | 2019 | 50 | 0.830 |
Why?
|
| Myringosclerosis | 2 | 2018 | 2 | 0.810 |
Why?
|
| Adult | 30 | 2022 | 25648 | 0.800 |
Why?
|
| Tinnitus | 2 | 2014 | 21 | 0.770 |
Why?
|
| Middle Aged | 31 | 2020 | 25028 | 0.770 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2207 | 0.750 |
Why?
|
| Meniere Disease | 1 | 2020 | 14 | 0.740 |
Why?
|
| Humans | 58 | 2023 | 86643 | 0.740 |
Why?
|
| Osteomyelitis | 2 | 2019 | 54 | 0.720 |
Why?
|
| Otosclerosis | 1 | 2019 | 6 | 0.710 |
Why?
|
| Osseointegration | 1 | 2019 | 11 | 0.700 |
Why?
|
| Otolaryngologists | 1 | 2019 | 4 | 0.700 |
Why?
|
| Ciprofloxacin | 1 | 2019 | 29 | 0.690 |
Why?
|
| Electroconvulsive Therapy | 1 | 2019 | 24 | 0.690 |
Why?
|
| Multidetector Computed Tomography | 1 | 2019 | 54 | 0.680 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2018 | 6 | 0.670 |
Why?
|
| Job Satisfaction | 1 | 2019 | 73 | 0.670 |
Why?
|
| Ear Neoplasms | 1 | 2018 | 10 | 0.670 |
Why?
|
| Hearing Loss | 2 | 2017 | 56 | 0.660 |
Why?
|
| Hearing | 2 | 2018 | 59 | 0.650 |
Why?
|
| Ear Ossicles | 1 | 2018 | 10 | 0.650 |
Why?
|
| Neuroma, Acoustic | 2 | 2015 | 20 | 0.640 |
Why?
|
| Competency-Based Education | 1 | 2018 | 35 | 0.630 |
Why?
|
| Encephalocele | 2 | 2016 | 24 | 0.620 |
Why?
|
| Reoperation | 2 | 2017 | 597 | 0.610 |
Why?
|
| Male | 31 | 2020 | 40965 | 0.610 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 111 | 0.580 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2016 | 16 | 0.570 |
Why?
|
| Retrospective Studies | 13 | 2023 | 8489 | 0.570 |
Why?
|
| Female | 29 | 2020 | 44532 | 0.570 |
Why?
|
| Bone Diseases | 1 | 2016 | 54 | 0.560 |
Why?
|
| Round Window, Ear | 1 | 2015 | 3 | 0.550 |
Why?
|
| Deafness | 2 | 2015 | 47 | 0.550 |
Why?
|
| Child | 12 | 2022 | 6927 | 0.540 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 322 | 0.540 |
Why?
|
| Myocutaneous Flap | 1 | 2015 | 5 | 0.540 |
Why?
|
| Soft Tissue Injuries | 1 | 2015 | 12 | 0.540 |
Why?
|
| Semicircular Canals | 1 | 2015 | 30 | 0.540 |
Why?
|
| Meningitis | 1 | 2015 | 20 | 0.540 |
Why?
|
| Mobile Applications | 1 | 2016 | 63 | 0.530 |
Why?
|
| Clinical Competence | 2 | 2018 | 751 | 0.520 |
Why?
|
| Craniotomy | 1 | 2015 | 88 | 0.510 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 3 | 0.510 |
Why?
|
| Otomycosis | 1 | 2014 | 1 | 0.510 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 171 | 0.500 |
Why?
|
| Physical Examination | 1 | 2015 | 149 | 0.490 |
Why?
|
| Candidiasis | 1 | 2014 | 36 | 0.490 |
Why?
|
| Aspergillosis | 1 | 2014 | 41 | 0.490 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 160 | 0.480 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 185 | 0.480 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 582 | 0.470 |
Why?
|
| Adolescent | 11 | 2020 | 8981 | 0.460 |
Why?
|
| Surgical Flaps | 1 | 2015 | 241 | 0.450 |
Why?
|
| Young Adult | 8 | 2018 | 5976 | 0.450 |
Why?
|
| Audiometry, Pure-Tone | 4 | 2018 | 25 | 0.420 |
Why?
|
| Biomedical Research | 1 | 2016 | 376 | 0.420 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1169 | 0.390 |
Why?
|
| Internship and Residency | 2 | 2018 | 1004 | 0.380 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2501 | 0.370 |
Why?
|
| India | 2 | 2020 | 120 | 0.350 |
Why?
|
| HIV Infections | 1 | 2018 | 772 | 0.350 |
Why?
|
| Treatment Outcome | 10 | 2019 | 7993 | 0.330 |
Why?
|
| Aged | 17 | 2020 | 18415 | 0.330 |
Why?
|
| Vestibular Diseases | 1 | 2008 | 27 | 0.320 |
Why?
|
| Vestibular Nerve | 1 | 2008 | 33 | 0.320 |
Why?
|
| Cadaver | 2 | 2021 | 185 | 0.320 |
Why?
|
| Child, Preschool | 5 | 2018 | 3612 | 0.310 |
Why?
|
| Developing Countries | 2 | 2018 | 71 | 0.310 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2006 | 13 | 0.290 |
Why?
|
| Headache | 1 | 2006 | 73 | 0.280 |
Why?
|
| Endoscopy | 4 | 2023 | 332 | 0.250 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2004 | 9 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2016 | 2601 | 0.230 |
Why?
|
| Skull Neoplasms | 2 | 2008 | 30 | 0.220 |
Why?
|
| Mastoiditis | 2 | 2017 | 4 | 0.210 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 3640 | 0.210 |
Why?
|
| Infant | 3 | 2018 | 3046 | 0.200 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2019 | 3 | 0.180 |
Why?
|
| Myringoplasty | 1 | 2019 | 1 | 0.180 |
Why?
|
| Radiography | 4 | 2008 | 813 | 0.180 |
Why?
|
| Fascia | 1 | 2019 | 30 | 0.170 |
Why?
|
| Pediatricians | 1 | 2019 | 17 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2019 | 31 | 0.170 |
Why?
|
| Tonsillectomy | 1 | 2019 | 30 | 0.170 |
Why?
|
| Oncologists | 1 | 2019 | 36 | 0.170 |
Why?
|
| Cartilage | 1 | 2019 | 113 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 3 | 1995 | 1052 | 0.170 |
Why?
|
| Skull Base | 1 | 2019 | 47 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2015 | 3362 | 0.170 |
Why?
|
| Necrosis | 1 | 2019 | 204 | 0.170 |
Why?
|
| Hospital Departments | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hospitals, Special | 1 | 2018 | 7 | 0.160 |
Why?
|
| Hospitals, Public | 1 | 2018 | 15 | 0.160 |
Why?
|
| Bone Conduction | 1 | 2018 | 5 | 0.160 |
Why?
|
| Granulation Tissue | 1 | 2018 | 15 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 66 | 0.160 |
Why?
|
| Otitis | 1 | 2017 | 2 | 0.160 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 107 | 0.150 |
Why?
|
| Ear Canal | 2 | 2014 | 13 | 0.150 |
Why?
|
| Otoscopy | 1 | 2016 | 1 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 6509 | 0.150 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 331 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2016 | 32 | 0.140 |
Why?
|
| Prevalence | 1 | 2020 | 1239 | 0.140 |
Why?
|
| Smartphone | 1 | 2016 | 36 | 0.140 |
Why?
|
| Ear, Inner | 1 | 1996 | 33 | 0.140 |
Why?
|
| Carcinoma, Medullary | 1 | 1995 | 11 | 0.140 |
Why?
|
| Mediastinal Emphysema | 1 | 1995 | 6 | 0.140 |
Why?
|
| Goals | 1 | 2016 | 67 | 0.140 |
Why?
|
| Temporal Arteries | 1 | 2015 | 9 | 0.140 |
Why?
|
| Biopsy | 3 | 2013 | 1163 | 0.140 |
Why?
|
| Nasal Sprays | 1 | 2015 | 9 | 0.130 |
Why?
|
| Incidental Findings | 1 | 2016 | 95 | 0.130 |
Why?
|
| Diatrizoate | 1 | 1995 | 15 | 0.130 |
Why?
|
| Plasma Substitutes | 1 | 1995 | 9 | 0.130 |
Why?
|
| Ear, External | 1 | 2015 | 26 | 0.130 |
Why?
|
| Telemetry | 1 | 2015 | 38 | 0.130 |
Why?
|
| Dextrans | 1 | 1995 | 77 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2016 | 185 | 0.130 |
Why?
|
| Branchioma | 1 | 1995 | 1 | 0.130 |
Why?
|
| Mouthwashes | 1 | 1994 | 5 | 0.130 |
Why?
|
| Tongue Diseases | 1 | 1994 | 8 | 0.130 |
Why?
|
| Cerebellopontine Angle | 1 | 1994 | 7 | 0.130 |
Why?
|
| Simulation Training | 1 | 2016 | 88 | 0.130 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1994 | 15 | 0.130 |
Why?
|
| Premedication | 1 | 1994 | 54 | 0.130 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1994 | 23 | 0.130 |
Why?
|
| Indium Radioisotopes | 1 | 1994 | 10 | 0.130 |
Why?
|
| Operative Time | 1 | 2015 | 127 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 1 | 1994 | 36 | 0.130 |
Why?
|
| Clavicle | 1 | 1994 | 11 | 0.130 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 55 | 0.120 |
Why?
|
| Fractures, Spontaneous | 1 | 1994 | 11 | 0.120 |
Why?
|
| Abscess | 1 | 1994 | 91 | 0.120 |
Why?
|
| Patient Positioning | 1 | 2015 | 63 | 0.120 |
Why?
|
| Parotitis | 1 | 1994 | 6 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2015 | 278 | 0.120 |
Why?
|
| Humeral Fractures | 1 | 1994 | 16 | 0.120 |
Why?
|
| Biopsy, Needle | 2 | 1994 | 235 | 0.120 |
Why?
|
| Debridement | 1 | 2014 | 56 | 0.120 |
Why?
|
| Mandibular Neoplasms | 1 | 1994 | 24 | 0.120 |
Why?
|
| Arteries | 1 | 2015 | 176 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2015 | 109 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1994 | 33 | 0.120 |
Why?
|
| Bronchoscopy | 1 | 1995 | 152 | 0.120 |
Why?
|
| Radius Fractures | 1 | 1994 | 30 | 0.120 |
Why?
|
| Lightning Injuries | 1 | 1993 | 2 | 0.120 |
Why?
|
| Tomography, X-Ray | 1 | 2013 | 18 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2016 | 839 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 746 | 0.120 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1993 | 7 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2014 | 117 | 0.120 |
Why?
|
| Sweating, Gustatory | 1 | 1993 | 1 | 0.120 |
Why?
|
| Sweat Glands | 1 | 1993 | 6 | 0.120 |
Why?
|
| Mycosis Fungoides | 1 | 1993 | 23 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 1994 | 144 | 0.110 |
Why?
|
| Leukocytes | 1 | 1994 | 202 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 344 | 0.110 |
Why?
|
| Nasal Septum | 1 | 1993 | 28 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2015 | 352 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2705 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 1994 | 184 | 0.110 |
Why?
|
| Adenoma | 1 | 1995 | 235 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2016 | 770 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 1186 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 121 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1805 | 0.100 |
Why?
|
| Anticoagulants | 1 | 1995 | 408 | 0.100 |
Why?
|
| Curriculum | 1 | 2016 | 539 | 0.100 |
Why?
|
| Graft Survival | 1 | 2015 | 884 | 0.100 |
Why?
|
| Aging | 1 | 2016 | 691 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 1995 | 408 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1801 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 1076 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 1993 | 321 | 0.090 |
Why?
|
| Contrast Media | 1 | 1995 | 1078 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1994 | 426 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2015 | 1065 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2015 | 2261 | 0.090 |
Why?
|
| Spiral Ganglion | 2 | 2001 | 25 | 0.090 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2008 | 12 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 1994 | 621 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 2767 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 1993 | 546 | 0.080 |
Why?
|
| Time Factors | 1 | 2017 | 5210 | 0.080 |
Why?
|
| Photography | 1 | 2007 | 37 | 0.080 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.080 |
Why?
|
| Decision Trees | 1 | 2007 | 63 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 1313 | 0.070 |
Why?
|
| Cranial Sinuses | 1 | 2006 | 15 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2007 | 272 | 0.070 |
Why?
|
| Risk | 1 | 2007 | 674 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 212 | 0.060 |
Why?
|
| Skull Fractures | 1 | 2004 | 24 | 0.060 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2003 | 2 | 0.060 |
Why?
|
| Otitis Media, Suppurative | 1 | 2003 | 4 | 0.060 |
Why?
|
| Tuberculosis, Miliary | 1 | 2003 | 4 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2007 | 971 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 5417 | 0.050 |
Why?
|
| Tobramycin | 1 | 2001 | 10 | 0.050 |
Why?
|
| Gentamicins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Hair Cells, Auditory | 1 | 2001 | 23 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 636 | 0.050 |
Why?
|
| Seizures | 1 | 2004 | 297 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2003 | 186 | 0.050 |
Why?
|
| Hearing Tests | 1 | 2019 | 10 | 0.040 |
Why?
|
| Transplants | 1 | 2019 | 40 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2001 | 894 | 0.040 |
Why?
|
| Geniculate Ganglion | 1 | 1996 | 2 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1996 | 7 | 0.040 |
Why?
|
| Dissection | 1 | 1996 | 42 | 0.030 |
Why?
|
| Subcutaneous Emphysema | 1 | 1995 | 7 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 2262 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1139 | 0.030 |
Why?
|
| Anthropometry | 1 | 1996 | 74 | 0.030 |
Why?
|
| Labyrinthitis | 1 | 1995 | 2 | 0.030 |
Why?
|
| Audiometry | 1 | 1995 | 16 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 1995 | 31 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 74 | 0.030 |
Why?
|
| Iodine | 1 | 1994 | 43 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1994 | 10 | 0.030 |
Why?
|
| Choristoma | 1 | 1995 | 68 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1994 | 63 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1995 | 429 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1995 | 144 | 0.030 |
Why?
|
| Carotid Sinus | 1 | 1994 | 24 | 0.030 |
Why?
|
| Gadolinium | 1 | 1994 | 103 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 1994 | 42 | 0.030 |
Why?
|
| Syncope | 1 | 1994 | 34 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1994 | 220 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1994 | 293 | 0.030 |
Why?
|
| Sezary Syndrome | 1 | 1993 | 8 | 0.030 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 1993 | 15 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 7 | 0.030 |
Why?
|
| Siloxanes | 1 | 1993 | 5 | 0.030 |
Why?
|
| Rupture | 1 | 1993 | 63 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1993 | 148 | 0.030 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 1994 | 118 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 1993 | 87 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 1993 | 89 | 0.030 |
Why?
|
| Mouth Neoplasms | 1 | 1994 | 194 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 1993 | 172 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 999 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 1565 | 0.020 |
Why?
|
| Skin | 1 | 1993 | 554 | 0.020 |
Why?
|
| Age Factors | 1 | 1993 | 1851 | 0.020 |
Why?
|
| Prognosis | 1 | 1994 | 3679 | 0.020 |
Why?
|
| Developed Countries | 1 | 2003 | 24 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 2003 | 52 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2003 | 59 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 248 | 0.010 |
Why?
|
| Cell Death | 1 | 2001 | 256 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 916 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1961 | 0.010 |
Why?
|
| Cell Count | 1 | 1995 | 195 | 0.010 |
Why?
|
| Cell Survival | 1 | 1995 | 969 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1994 | 486 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 2438 | 0.010 |
Why?
|